Ann Dermatol.  2018 Oct;30(5):630-633. 10.5021/ad.2018.30.5.630.

Increased Immunoreactivity of LGR4 in Histologically Aggressive Basal Cell Carcinoma

• Oh ST
• Lee J
• Yang KJ
• Bae JM
• Park HJ
• Kim JW
• Park YM

• KMID: 2419763
• DOI: http://doi.org/10.5021/ad.2018.30.5.630

Abstract

No abstract available.

MeSH Terms

Carcinoma, Basal Cell*

Figure

• 

  Fig. 1 (A) Notice decreased immunoreactivity in nodular BCC (×100). (B) Notice marked increased nuclear and cytoplasmic LGR4 expression in infiltrative BCC (×200) and (C) at the invasive front of nodular-infiltrative BCC (×100). The white arrow highlights the area magnified in (D) (×200). The black arrow highlights the area magnified in (E) (×200).

Reference

1. Kim HS, Park JM, Mun JH, Song M, Ko HC, Kim BS, et al. Usefulness of dermatoscopy for the preoperative assessment of the histopathologic aggressiveness of basal cell carcinoma. Ann Dermatol. 2015; 27:682–687. PMID: 26719636.

2. Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, Verhaegen ME, et al. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell. 2015; 16:400–412. PMID: 25842978.

3. Barker N, Clevers H. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 2010; 138:1681–1696. PMID: 20417836.

4. Yi J, Xiong W, Gong X, Bellister S, Ellis LM, Liu Q. Analysis of LGR4 receptor distribution in human and mouse tissues. Plos One. 2013; 8:e78144. PMID: 24205130.

5. Xu P, Dang Y, Wang L, Liu X, Ren X, Gu J, et al. LGR4 is crucial for skin carcinogenesis by regulating MEK/ERK and Wnt/β-catenin signaling pathways. Cancer Lett. 2016; 383:161–170. PMID: 27693558.

6. Carmon KS, Gong X, Lin Q, Thomas A, Liu Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proc Natl Acad Sci U S A. 2011; 108:11452–11457. PMID: 21693646.

7. Wu J, Xie N, Xie K, Zeng J, Cheng L, Lei Y, et al. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer. Carcinogenesis. 2013; 34:2861–2869. PMID: 23803691.

8. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol. 1990; 23(6 Pt 1):1118–1126. PMID: 2273112.

9. Cohen PR, Schulze KE, Nelson BR. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg. 2006; 32:542–551. PMID: 16681663.

10. Oh ST, Kim HS, Yoo NJ, Lee WS, Cho BK, Reichrath J. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma. Br J Dermatol. 2011; 165:1197–1204. PMID: 21729023.